News and Updates

Keeping You Well-Informed

ThedaCare Continues Effective Monoclonal Antibody Infusion Treatment for COVID-19

ThedaCare Continues Effective Monoclonal Antibody Infusion Treatment for COVID-19

Team Member Dedication Supports Successful Program    As another surge of COVID-19 infections began to develop in Northeast and Central Wisconsin in the fall of 2021, ThedaCare went into action to help community members diagnosed with the virus through Monoclonal antibody treatments.     Monoclonal antibodies (mAbs) can help prevent or reduce hospitalization, reduce viral loads and lessen the severity of COVID-19 symptoms. The Federal Drug Administration (FDA) gave emergency use authorization (EUA) to mAbs for the treatment of COVID-19 patients at high risk of developing a serious infection.     “Monoclonal antibodies are effective when given early in the course...

Read More

For the Press


Media Contact

Cassandra Wallace

For further media resources or to submit media requests, please contact Cassandra Wallace, ThedaCare Public Relations Specialist. Phone: 920.442.0328 Email: cassandra.wallace@thedacare.org

Mayo Clinic Care Network logo

Resources

Here you can access the latest COVID-19 updates from ThedaCare and our clinical collaborator, Mayo Clinic, as well as prevention tips, facts and other healthcare resources.

Patient and Visitor

Visitor Information

What you need to know before visiting patients at ThedaCare

Online care options

Care Options

ThedaCare offers a variety of online care options for both new and current patients